Bioventus Inc. (NASDAQ:BVS) Q1 2026 Earnings Call Transcript
Bioventus Inc. (NASDAQ:BVS) Q1 2026 Earnings Call Transcript May 6, 2026Bioventus Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $0.09.
Bioventus Inc. (BVS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Juniper Investment Company Alexis Michas And John Bartholdson | 6,939,357 | $65,507,530 | 17.35% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 6,000,279 | $56,642,634 | -2% | 1.87% |
| 3. | Royce & Associates Chuck Royce | 1,833,212 | $17,305,521 | +19% | 0.14% |
| 4. | Engine Capital Arnaud Ajdler | 900,558 | $8,501,268 | +186% | 0.83% |
| 5. | Renaissance Technologies Jim Simons | 736,000 | $6,947,840 | +51% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.55 | 25,500 | $217,966.35 | 6,939,357 | 2024-08-19 | Filing | |
| $8.55 | 80,000 | $683,736.00 | 6,913,857 | 2024-08-16 | Filing | |
| $4.14 | 26,595 | $110,071.39 | 26,595 | 2023-08-18 | Filing | |
| $4.14 | 13,290 | $55,004.65 | 138,290 | 2023-08-18 | Filing | |
| $4.79 | 14,985 | $71,752.68 | 6,833,857 | 2023-08-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.79 | 12,000 | $105,439.20 | 44,997 | 2026-03-11 | Filing | |
| $7.57 | 10,000 | $75,658.00 | 116,610 | 2025-12-04 | Filing | |
| $7.42 | 17,701 | $131,254.69 | 56,997 | 2025-11-07 | Filing | |
| $7.57 | 3,875 | $29,333.75 | 141,088 | 2025-04-11 | Filing | |
| $7.57 | 2,958 | $22,392.06 | 131,416 | 2025-04-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,021,324 | $122,921,299 | 48.35% | |
| 2. | 3,435,914 | $32,435,028 | 0% | |
| 3. | 1,751,678 | $16,535,840 | 0% | |
| 4. | 1,365,716 | $12,894,139 | 0% | |
| 5. | 1,353,415 | $12,776,238 | 0.01% |
News See All
Bioventus Inc. (NASDAQ:BVS) Q4 2025 Earnings Call Transcript
Bioventus Inc. (NASDAQ:BVS) Q4 2025 Earnings Call Transcript March 5, 2026Bioventus Inc. misses on earnings expectations. Reported EPS is $0.2141 EPS, expectations were $0.22.
Bioventus Inc. (NASDAQ:BVS) Q3 2025 Earnings Call Transcript
Bioventus Inc. (NASDAQ:BVS) Q3 2025 Earnings Call Transcript November 4, 2025Bioventus Inc. misses on earnings expectations. Reported EPS is $0.04583 EPS, expectations were $0.215.
Craig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PT
Bioventus Inc. (NASDAQ:BVS) is one of the best medical device stocks to buy according to analysts. On August 7, Craig-Hallum analyst Chase Knickerbocker reiterated a Buy rating on Bioventus Inc.
12 Best Medical Device Stocks to Buy According to Analysts
In this article, we will look at the 12 Best Medical Device Stocks to Buy According to Analysts.
Bioventus Inc. (NASDAQ:BVS) Q2 2025 Earnings Call Transcript
Bioventus Inc. (NASDAQ:BVS) Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Thank you for standing by. My name is Carly, and I will be your conference operator today.
10 Undervalued Medical Device Stocks to Buy Now
In this article, we will look at the 10 Undervalued Medical Device Stocks to Buy Now. According to a report by Mordor Intelligence, the medical device industry is valued at $681.57 billion as of 2025.
Bioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call Transcript
Bioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call Transcript May 6, 2025Bioventus Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $0.06.
Bioventus Inc. (NASDAQ:BVS) Q4 2024 Earnings Call Transcript
Bioventus Inc. (NASDAQ:BVS) Q4 2024 Earnings Call Transcript March 11, 2025Bioventus Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $0.08.
Bioventus Inc. (NASDAQ:BVS) Q3 2024 Earnings Call Transcript
Bioventus Inc. (NASDAQ:BVS) Q3 2024 Earnings Call Transcript November 5, 2024Bioventus Inc. reports earnings inline with expectations. Reported EPS is $0.06 EPS, expectations were $0.06.
Hedge Fund Resource Center